Home/Filings/4/0001235802-18-000101
4//SEC Filing

Asper Jason D. 4

Accession 0001235802-18-000101

CIK 0001492658other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 4:14 PM ET

Size

7.5 KB

Accession

0001235802-18-000101

Insider Transaction Report

Form 4
Period: 2018-07-24
Asper Jason D.
Sr VP, Strategy & Corp. Dev.
Transactions
  • Award

    Ordinary Shares, par value EUR 0.03 per share

    2018-07-24+4,65816,979 total
  • Award

    Stock Option (right to buy)

    2018-07-24+12,49912,499 total
    Exercise: $24.49Exp: 2028-07-24Ordinary Shares (12,499 underlying)
Footnotes (3)
  • [F1]These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
  • [F2]Includes 16,979 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
  • [F3]This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001714435

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:14 PM ET
Size
7.5 KB